| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-08 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-07 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |